Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
EXL-01 by Exeliom Biosciences for Gastric Cancer: Likelihood of Approval
EXL-01 is under clinical development by Exeliom Biosciences and currently in Phase II for Gastric Cancer. According to GlobalData, Phase...
Data Insights
EXL-01 by Exeliom Biosciences for Clostridioides difficile Infections (Clostridium difficile Associated Disease): Likelihood of Approval
EXL-01 is under clinical development by Exeliom Biosciences and currently in Phase II for Clostridioides difficile Infections (Clostridium difficile Associated...